Home / Inspections / 964002

FDA Inspection 964002 — Everest Life Sciences LLC

Everest Life Sciences LLC — FEI 2243092

The FDA completed an inspection of Everest Life Sciences LLC on March 16, 2016 in Plainsboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 16, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Plainsboro, NJ (United States)

Facility

Other inspections at this facility

  • 1267697 (VAI Wed Apr 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1071273 (VAI Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1063269 (NAI Fri Jul 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 778012 (VAI Mon Apr 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 710185 (VAI Fri Feb 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources